Home/Genenta Science/Kleanthis G. Xanthopoulos
KG

Kleanthis G. Xanthopoulos

Chairman of the Board of Directors

Genenta Science

Genenta Science Pipeline

DrugIndicationPhase
TemferonNewly Diagnosed Unmethylated Glioblastoma Multiforme (GBM)Phase 1/2